OOIR: Observatory of International Research

Papers

(The H4-Index of Molecular Oncology is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Issue Information	222
	111
Issue Information	100
	87
Corrigendum to: Small proline‐rich repeat protein 3 enhances the sensitivity of esophageal cancer cells in response to DNA damage‐induced apoptosis	78
Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1	70
An arms‐race against resistance: leukemic stem cells and lineage plasticity	68
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer	65
Whole‐genome sequencing of cell‐free DNA reveals DNA of tumor origin in plasma from patients with colorectal adenomas	58
Correction to “SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression”	56
Correction to “Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition”	56
Nanosecond pulsed electric field ablation‐induced modulation of sphingolipid metabolism is associated with Ly6c2⁺ mononuclear phagocyte differentiation in liver cancer	54
NKG2A and circulating extracellular vesicles are key regulators of natural killer cell activity in prostate cancer after prostatectomy	53
Vandetanib drives growth arrest and promotes sensitivity to imatinib in chronic myeloid leukemia by targeting ephrin type‐B receptor 4	51
Prognostic and predictive impact of gene expression in node‐positive early breast cancer patients receiving dose‐dense versus standard‐dose adjuvant chemotherapy	44
Unraveling the metastasis‐preventing effect of miR‐200c in vitro and in vivo	43
ERK signaling controls productive HIF‐1 binding to chromatin and cancer cell adaptation to hypoxia through HIF‐1α interaction with NPM1	42
Exosomes secreted by ST3GAL5^high cancer cells promote peritoneal dissemination by establishing a premetastatic microenvironment	40
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient‐derived orthotopic xenografts, cell lines and tumor entities	39
TGFβ selects for pro‐stemness over pro‐invasive phenotypes during cancer cell epithelial–mesenchymal transition	39
Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1–NDRG1 deregulation	36
Cancer‐associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T‐cell suppression	35
Ovarian cancer relies on the PDGFRβ–fibronectin axis for tumorsphere formation and metastatic spread	34
Interaction between membranous EBP50 and myosin 9 as a favorable prognostic factor in ovarian clear cell carcinoma	34
Peripheral blood leukocyte signatures as biomarkers in relapsed ovarian cancer patients receiving combined anti‐CD73/anti‐PD‐L1 immunotherapy in arm A of the NSGO	33

Lysosome‐dependent FOXA1 ubiquitination contributes to luminal lineage of advanced prostate cancer	32
Gene signature predicting recurrence in oral squamous cell carcinoma is characterized by increased oxidative phosphorylation	32
Development of an optimized, non‐stem cell line for intranasal delivery of therapeutic cargo to the central nervous system	32
Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection	32
Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling	30
Early assessment of circulating tumor DNA after curative‐intent resection predicts tumor recurrence in early‐stage and locally advanced non‐small‐cell lung cancer	30